CSF2 and neoplasm: Similarly, adding cytokines that stimulate the immune system such as IFN-a, IL-2, IL-12, IL-10 and the granulocyte-macrophage colony-stimulating factor (GM-CSF) to the treatment regimen or at high concentrations directly into the tumor microenvironment may also alter immune responses[243].